Zhejiang Jolly PharmaceuticalLTD Balance Sheet Health
Financial Health criteria checks 6/6
Zhejiang Jolly PharmaceuticalLTD has a total shareholder equity of CN¥2.7B and total debt of CN¥243.7M, which brings its debt-to-equity ratio to 9%. Its total assets and total liabilities are CN¥3.9B and CN¥1.2B respectively. Zhejiang Jolly PharmaceuticalLTD's EBIT is CN¥554.2M making its interest coverage ratio -38.6. It has cash and short-term investments of CN¥925.9M.
Key information
9.0%
Debt to equity ratio
CN¥243.66m
Debt
| Interest coverage ratio | -38.6x |
| Cash | CN¥925.91m |
| Equity | CN¥2.72b |
| Total liabilities | CN¥1.18b |
| Total assets | CN¥3.89b |
Recent financial health updates
No updates
Recent updates
We Ran A Stock Scan For Earnings Growth And Zhejiang Jolly PharmaceuticalLTD (SZSE:300181) Passed With Ease
Jul 29
Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181) Held Back By Insufficient Growth Even After Shares Climb 28%
May 13A Look At The Fair Value Of Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181)
May 08There's No Escaping Zhejiang Jolly Pharmaceutical Co.,LTD's (SZSE:300181) Muted Earnings
Mar 01Financial Position Analysis
Short Term Liabilities: 300181's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥1.1B).
Long Term Liabilities: 300181's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥50.7M).
Debt to Equity History and Analysis
Debt Level: 300181 has more cash than its total debt.
Reducing Debt: 300181's debt to equity ratio has reduced from 30% to 9% over the past 5 years.
Debt Coverage: 300181's debt is well covered by operating cash flow (156.2%).
Interest Coverage: 300181 earns more interest than it pays, so coverage of interest payments is not a concern.